These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 3139358

  • 1. Plasma glucose and insulin levels in women using a levonorgestrel-containing triphasic oral contraceptive for three months.
    Spellacy WN, Ellingson AB, Kotlik A, Tsibris JC.
    Contraception; 1988 Jul; 38(1):27-35. PubMed ID: 3139358
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of a new triphasic oral contraceptive in private practice.
    Ellsworth HS, Ayerst RI, Harris JW, Stone RA, Anderson AE, Jones TL, Curtis MK.
    Contraception; 1986 Nov; 34(5):435-42. PubMed ID: 3102161
    [Abstract] [Full Text] [Related]

  • 3. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
    Notelovitz M, Kitchens CS, Khan FY.
    Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
    [Abstract] [Full Text] [Related]

  • 4. The short-term effects of a low-dose oral contraceptive on glucose metabolism, plasma lipids and blood clotting factors.
    Skouby SO, Wagner HH, Andersen O.
    Contraception; 1983 Nov; 28(5):489-99. PubMed ID: 6425010
    [Abstract] [Full Text] [Related]

  • 5. Comparative metabolic effects of three types of combined oral contraceptive pills in Chinese women.
    Prasad RN, Liew D, Ratnam SS.
    Contraception; 1989 Jan; 39(1):21-35. PubMed ID: 2521321
    [Abstract] [Full Text] [Related]

  • 6. Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease.
    Godsland IF, Crook D, Devenport M, Wynn V.
    Contraception; 1995 Sep; 52(3):143-9. PubMed ID: 7587185
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel.
    Song S, Chen JK, Yang PJ, He ML, Li LM, Fan BC, Rekers H, Fotherby K.
    Contraception; 1992 Jun; 45(6):523-32. PubMed ID: 1535580
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prospective study of carbohydrate metabolism in women using a triphasic oral contraceptive containing norethindrone and ethinyl estradiol for 3 months.
    Spellacy WN, Ellingson AB, Kotlik A, Tsibris JC.
    Am J Obstet Gynecol; 1988 Oct; 159(4):877-9. PubMed ID: 3052079
    [Abstract] [Full Text] [Related]

  • 11. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
    Godsland IF, Crook D, Simpson R, Proudler T, Felton C, Lees B, Anyaoku V, Devenport M, Wynn V.
    N Engl J Med; 1990 Nov 15; 323(20):1375-81. PubMed ID: 2146499
    [Abstract] [Full Text] [Related]

  • 12. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V.
    Contracept Fertil Sex (Paris); 1985 Jan 15; 13(1 Suppl):425-30. PubMed ID: 12280210
    [Abstract] [Full Text] [Related]

  • 13. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G, Powell M, Marshall A, Woutersz TB, Steiner G.
    Int J Fertil Menopausal Stud; 1994 Jan 15; 39(5):283-91. PubMed ID: 7820162
    [Abstract] [Full Text] [Related]

  • 14. Six-month carbohydrate metabolism studies in women using oral contraceptives containing gestodene and ethinyl estradiol.
    Spellacy WN, Tsibris JC, Hunter-Bonner DL, Smalling S, Chez RA, Angel JL, O'Brien WF.
    Contraception; 1992 Jun 15; 45(6):533-9. PubMed ID: 1617962
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Oral contraceptives and insulin receptor binding in normal women and those with previous gestational diabetes.
    Skouby SO, Andersen O, Kühl C.
    Am J Obstet Gynecol; 1986 Oct 15; 155(4):802-7. PubMed ID: 3766633
    [Abstract] [Full Text] [Related]

  • 17. A comparison study of lipid and androgen metabolism with triphasic oral contraceptive formulations containing norgestimate or levonorgestrel.
    Janaud A, Rouffy J, Upmalis D, Dain MP.
    Acta Obstet Gynecol Scand Suppl; 1992 Oct 15; 156():33-8. PubMed ID: 1324555
    [Abstract] [Full Text] [Related]

  • 18. [Effect of an oral contraceptive (ethinylestradiol/D-norgestrel) on growth hormone and insulin secretion].
    Hausmann L, Goebel KM, Zehner J.
    Schweiz Med Wochenschr; 1976 Oct 23; 106(43):1470-4. PubMed ID: 1013665
    [Abstract] [Full Text] [Related]

  • 19. Phasic approach to oral contraceptives.
    Hale RW.
    Am J Obstet Gynecol; 1987 Oct 23; 157(4 Pt 2):1052-8. PubMed ID: 3118718
    [Abstract] [Full Text] [Related]

  • 20. Carbohydrate metabolic studies in women using a levonorgestrel/ethinyl estradiol containing triphasic oral contraceptive for eighteen months.
    Spellacy WN, Tsibris JC, Ellingson AB.
    Int J Gynaecol Obstet; 1991 May 23; 35(1):69-71. PubMed ID: 1680079
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.